Prelude Capital Management, LLC Abb Vie Inc. Put Options Transaction History

Prelude Capital Management, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $1.44 Million - $1.81 Million	20,000 Added 150.38%	33,300 $2.95 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $1.61 Million - $1.94 Million	-25,600 Reduced 65.81%	13,300 $1.01 Million
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $2.04 Million - $2.61 Million	-31,100 Reduced 44.43%	38,900 $2.83 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $7,714 - $9,079	-100 Reduced 0.14%	70,000 $5.64 Million
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $5.46 Million - $6.73 Million	70,100 New	70,100 $6.46 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.